Search Results 221-230 of 14841 for alt

1. Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors - Mayo Clinic

   AST/ALT ≤ 3 x ULN and total bilirubin ≤ 2.0 x ULN. In metastatic disease to the liver, AST/ALT may be ≤ 5x ULN and total bilirubin ≤ 2.5 x ULN. If known ...

2. Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib - Mayo Clinic

   Participation eligibility · Total Bilirubin ≤2.0 times institutional ULN · Alanine Aminotransferase (ALT) ≤2.5 times the institutional ULN · Aspartate ...

3. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

   Aspartate transaminase (AST) or alanine transaminase (ALT) > 2.5 x ... ALT and alkaline phosphatase meet the protocol-specified levels for eligibility); ...

4. Liver transplant - Doctors & Departments - Mayo Clinic

   Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

5. Testing A Standardized Approach To Surgery And Chemotherapy For Type I Pleuropulmonary Blastoma Or The Addition Of An Anti-cancer Drug, Topotecan, To The Usual Treatment For Types II And III Pleuropulmonary Blastoma - Mayo Clinic

   ... [ALT]) ≤ 135 U/L. Note: For the purpose of this study, the ULN for SGPT (ALT) has been set to the value of 45 U/L. Shortening fraction of ≥ 27% by ...

6. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

   ALT ≤1.5 x ULN. Total bilirubin within institutional normal limits. Creatinine ≤1.5 x ULN. Exclusion Criteria: Current or previous evidence of muscle ...

7. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial - Mayo Clinic

   ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...

8. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   ... (ALT) has been set to the value of 45 U/L * Shortening fraction of ≥ 27% by echocardiogram, or * Ejection fraction of ≥ 50% by radionuclide angiogram * No ...

9. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

   ALT and AST ≤ 3 × ULN unless liver metastases are present in which case patients are included; if ALT and AST ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN; OR ...

10. Pediatric white blood cell disorders - Symptoms and causes - Mayo Clinic

    Eosinophils. Eosinophilia (e-o-sin-o-FIL-e-uh) is a having too many eosinophil cells. These cells help with swelling and irritation, called inflammation. They ...